Celator Pharmaceuticals Inc. (CPXX) announced Tuesday morning that it has agreed to be acquired by Jazz Pharmaceuticals (JAZZ) for $30.25 per share in cash, or approximately $1.5 billion.
from RTT - Before the Bell http://ift.tt/1UdDlJn
via IFTTT
No comments:
Post a Comment